William Mack & Associates
MDT icon

William Mack & Associates’s Medtronic MDT Stock Holding History

William Mack & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92K Buy
+1,066
New +$93.9K 0.03% 176

Other funds holding MDT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

William Mack & Associates's MDT Position: Q3 2026 in Review

William Mack & Associates opened a new position in Medtronic (MDT) in Q3 2026: 1,066 shares worth $92K. The stake represents 0.03% of the portfolio and ranks #176 among its holdings.

1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • William Mack & Associates held 1,066 shares of Medtronic worth $92K as of Q3 2026.
  • Medtronic was a new William Mack & Associates position in Q3 2026.
  • Medtronic made up 0.03% of William Mack & Associates's portfolio in Q3 2026, its #176 holding.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.